Xconomy National

Archives

by in

Entry	Author	Date	Location
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO	Luke Timmerman	12/06/11	Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News	Luke Timmerman	09/29/11	Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News	Luke Timmerman	09/22/11	Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic	Luke Timmerman	09/21/11	Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu	Arlene Weintraub	04/28/11	New York
VBI Progressing with Vaccines That Don’t Require Refrigeration	Ryan McBride	03/24/11	Boston
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies	Luke Timmerman	03/08/11	Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections	Luke Timmerman	01/18/11	Seattle
NanoBio Passes First Key Clinical Trial With Nasal Flu Vaccine, Scopes Other Opportunities	Luke Timmerman	09/16/10	Detroit
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences	Luke Timmerman	09/16/10	Seattle
PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions	Luke Timmerman	09/15/10	Seattle
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences	Ryan McBride	08/16/10	Boston
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three	Luke Timmerman	07/27/10	Seattle
Visterra, Previously Parasol, Expands with $6M	Gregory T. Huang	07/12/10	Boston
Theraclone Sciences CEO David Fanning Dies Suddenly	Luke Timmerman	06/14/10	Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News	Luke Timmerman	06/11/10	Seattle
AVI Biopharma Gets $18M Flu Contract	Luke Timmerman	06/07/10	Seattle
FDA OK’s IMDx H1N1 Test	Erin Kutz	03/24/10	Boston
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug	Luke Timmerman	02/01/10	Seattle
The Top Five Biotech Innovations of the 2000s	Clay Siegall	12/15/09	Seattle
Quidel OKs $25M in Share Buybacks	Luke Timmerman	12/08/09	San Diego
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters	Luke Timmerman	11/10/09	Seattle
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic	Luke Timmerman	11/03/09	Seattle
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs	Luke Timmerman	11/02/09	Boston
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego	Bruce V. Bigelow	10/27/09	San Diego
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News	Luke Timmerman	10/08/09	Seattle
Veratect Secures $4.2M Debt	Luke Timmerman	10/06/09	Seattle
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News	Gregory T. Huang	10/06/09	Seattle
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company	Luke Timmerman	10/05/09	Seattle
It’s About Health Care, Not Health Insurance	Norm Wu	09/28/09	Seattle
Page 1 of 2	next page »